Paris, France and Camberley, UK – 12 November 2020 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces that it has been notified that, on 11 November 2020, Graham Mullis, Chief Executive of the Company, acquired 60,875 ordinary shares of €1/15 each in the Company at a price of £8.17
Visit PageYear: 2020
Participations des Administrateurs / PERD
Paris, France et Camberley, Royaume-Uni – 11 novembre 2020 – Novacyt (EURONEXT GROWTH : ALNOV ; AIM : NCYT), spécialiste mondial du diagnostic clinique, annonce avoir été informé, le 10 novembre 2020, de l’achat par Edwin Snape, Administrateur non exécutif de la société, de 1 080 actions ordinaires de la société au prix de 1,15
Visit PageDirector/PDMR Shareholding
Paris, France and Camberley, UK – 11 November 2020 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces that it has been notified that, on 10 November 2020, Edwin Snape, a Non-Executive Director of the Company, purchased 1,080 ordinary shares of €1/15 each in the Company at a price of
Visit Page